Objectives: To explore new metrics for assessing radical prostatectomy difficulty through a two-stage deep learning method from preoperative magnetic resonance imaging.
Methods: The procedure and metrics were validated through 290 patients consisting of laparoscopic and robot-assisted radical prostatectomy procedures from two real cohorts. The nnUNet_v2 adaptive model was trained to perform accurate segmentation of the prostate and pelvis. A modified network PointNet was used for indirectly regressing 15 anatomical landmarks based on Gaussian heatmaps. Novel metrics proposed in this study that characterized the spatial relationship between the prostate and pelvis were included to evaluate the surgical difficulty.
Results: The two-stage process achieved decent segmentation and landmark localization results with the Mean Validation Dice of 0.8641 and millimeter-level accuracy. We found the coefficients of PV, ρ, PT, PAP, AG, PSD, PSD, πρ/ISTA, AG+PG, AG×PG, PSD×ρ, PAP/(AG+PG) with Estimated Blood Loss and PSD, PSD×ρ with Operation Time, respectively with statistic significant, which provides possibilities for assessing surgical difficulty evaluation. The entire pipeline had been validated on the external dataset, and the results were consistent.
Conclusions: The two-stage anatomical landmark localization approach is feasible. Indicators describing pelvic-prostate spatial constraints significantly impact surgical difficulty in radical prostatectomy, leading to increased blood loss and longer operation times, while isolated pelvic measurements have minimal effect on surgical outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.urology.2025.01.028 | DOI Listing |
Asian Pac J Cancer Prev
January 2025
Postgraduate Program in Oncology, Haroldo Juaçaba Hospital, Ceará Cancer Institute (ICC), Brazil.
Objective: This study aimed to investigate the influence of p16 immunohistochemical expression on the biochemical recurrence rate of pT2-pT3 prostate cancer.
Materials And Methods: A total of 488 pT2-pT3 stage prostate adenocarcinomas undergoing radical prostatectomy were included in this study. Following a review of Gleason classification and retrieval of sociodemographic and clinicopathological data, as well as the date of last consultation and biochemical recurrence, immunohistochemistry for p16 was performed.
Cancer Pathog Ther
January 2025
Department of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan 20162, Italy.
Res Rep Urol
January 2025
Department of Pathology, Faculty of Medicine, University of Botswana, Gaborone, Botswana.
Introduction: Prostate cancer (CaP) is the most common malignancy and the second leading cause of cancer-related deaths among men in Botswana. Currently, diagnosing CaP relies on examining prostate biopsy samples, which can be challenging due to benign mimics. This study aims to evaluate the potential of Alpha-methyl acyl-CoA racemase (AMACR/p504s) and p63, as diagnostic markers for CaP.
View Article and Find Full Text PDFBiol Res
January 2025
Department of Urology and Andrology, Renji Hospital, Shanghai Institute of Andrology, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
Background: Cavernous nerve injury-induced erectile dysfunction (CNI-ED) is a common complication following radical prostatectomy and severely affects patients' quality of life. The mitochondrial impairment in corpus cavernosum smooth muscle cells (CCSMCs) may be an important pathological mechanism of CNI-ED. Previous studies have shown that transplantation of human adipose derived stem cells (ADSC) can alleviate CNI-ED in a rat model.
View Article and Find Full Text PDFBMC Cancer
January 2025
Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
Background: This paper describes the rationale and design of the RECOVER study. Currently, there is no consensus regarding the optimal treatment for high-risk, non-metastatic prostate cancer (PCa). The study primarily aims to evaluate and compare the impact of treatment with robot-assisted radical prostatectomy (RP) versus external beam radiation therapy (EBRT) with androgen deprivation therapy (ADT) for men with high-risk, non-metastatic PCa regarding health-related quality of life (HRQoL) and functional outcomes.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!